The human oncogene SCL/TAL1 interrupting locus (STIL) promotes tumor growth through MAPK/ERK, PI3K/Akt and AMPK pathways in prostate cancer

Cancer statistics, 2014

Rebecca L. Siegel, Jiemin Ma, Zhaohui Zou et al. · CA A Cancer Journal for Clinicians · 2014 · 11.6K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

The AMPK signalling pathway coordinates cell growth, autophagy and metabolism

Maria M. Mihaylova, Reuben J. Shaw · Nature Cell Biology · 2011 · 2.9K citations · Full text

Life Sciences, Cell Biology, Molecular Biology +10

Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer: Updated Survival in the TAX 327 Study

Dominik Berthold, Gregory R. Pond, Freidele Soban et al. · Journal of Clinical Oncology · 2008 · 1.1K citations

Medicine, Oncology, Pharmacotherapy +17

Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer

Mercedes Marín‐Aguilera, Jordi Codony‐Servat, Òscar Reig et al. · Molecular Cancer Therapeutics · 2014 · 148 citations · Full text

Medicine, Oncology, Urology +17

Genistein inhibits the stemness properties of prostate cancer cells through targeting Hedgehog–Gli1 pathway

Linlin Zhang, Lei Li, Min Jiao et al. · Cancer Letters · 2012 · 120 citations

Medicine, Cell Biology, Oncology +16